Analyst Ratings For BioLife Solutions (NASDAQ:BLFS)
Today, Maxim Group reiterated its Buy rating on BioLife Solutions (NASDAQ:BLFS) with a price target of $5.00.
There are 2 buy ratings on the stock.
The current consensus rating on BioLife Solutions (NASDAQ:BLFS) is Buy (Score: 3.00) with a consensus target price of $5.00 per share, a potential 44.93% upside.
Some recent analyst ratings include
- 7/31/2017-Maxim Group Reiterated Rating of Buy.
- 7/5/2017-Janney Montgomery Scott Upgrade from a “Neutral ” rating to a ” Buy” rating.
- 2/19/2016-Aegis Reiterated Rating of Buy.
Recent Insider Trading Activity For BioLife Solutions (NASDAQ:BLFS)
BioLife Solutions (NASDAQ:BLFS) has insider ownership of 37.70% and institutional ownership of 2.06%.
- On 8/8/2014 Raymond W Cohen, Chairman, bought 1,250 with an average share price of $2.48 per share and the total transaction amounting to $3,100.00. View SEC Filing
- On 5/20/2014 Raymond W Cohen, Chairman, bought 4,000 with an average share price of $2.39 per share and the total transaction amounting to $9,560.00. View SEC Filing
- On 5/14/2014 Aby J Mathew, CTO, bought 8,600 with an average share price of $2.33 per share and the total transaction amounting to $20,038.00. View SEC Filing
- On 5/14/2014 Michael Rice, CEO, bought 8,000 with an average share price of $2.56 per share and the total transaction amounting to $20,480.00. View SEC Filing
- On 5/13/2014 Michael Rice, CEO, bought 12,767 with an average share price of $2.26 per share and the total transaction amounting to $28,853.42. View SEC Filing
Recent Trading Activity for BioLife Solutions (NASDAQ:BLFS)
Shares of BioLife Solutions closed the previous trading session at 3.45 down -0.05 -1.43% with 45,135 shares trading hands.